A Randomized Controlled Trial to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol
Status:
Completed
Trial end date:
2016-07-21
Target enrollment:
Participant gender:
Summary
This trial consists of 2 parts: a double-blinded phase and an open-label extension phase. The
blinded phase only will be described in this record. Participants were randomized in a 4:1
ratio to receive GWP42003-P or matching placebo.